Skip to content

Clinical trials

Phase 3 Thrombocytopenia trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 3 Country / region: Russia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20062
20081
20121
20132
20142
20181
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
AO GENERIUM2
CTI BioPharma2
Novartis Pharmaceuticals2
CSL Behring1
Eisai Inc.1
Pfizer1
Sobi, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia13
Purpura, Thrombocytopenic, Idiopathic6
Purpura4
Anemia2
Bone Marrow Diseases2
Ecchymosis2
Hematologic Diseases2
Hemorrhage2
Myeloproliferative Disorders2
Polycythemia Vera2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.